NAFLD, Helicobacter species and the intestinal microbiome

Area of Science:

• Hepatology
• Microbiome Research
• Gastroenterology

Background:

• Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease globally.
• Gut dysbiosis is recognized as a factor in NAFLD, though specific alterations remain debated.
• Helicobacter pylori infection is inconsistently linked to increased NAFLD risk.

Purpose of the Study:

• To explore the complex relationship between gut microbiome alterations, Helicobacter species, and NAFLD pathogenesis.
• To highlight the need for standardized methodologies in microbiota analysis and NAFLD diagnosis.
• To elucidate the multifactorial mechanisms contributing to NAFLD development.

Main Methods:

• Review of existing literature on gut dysbiosis and NAFLD.
• Analysis of studies investigating Helicobacter species and NAFLD association.
• Examination of proposed pathogenetic mechanisms involving the gut microbiome.

Main Results:

• Conflicting evidence exists regarding the precise nature of gut dysbiosis in NAFLD.
• Some studies associate Helicobacter pylori with higher NAFLD risk, while others do not.
• Multiple factors, including gut permeability, inflammation, and metabolic alterations, are implicated.

Conclusions:

• Further large-scale studies with standardized protocols are essential for clarifying the role of gut microbiota and Helicobacter in NAFLD.
• The pathogenesis of NAFLD likely involves a 'multiple-hit' process influenced by gut microbiome and Helicobacter species.
• Mechanisms include altered metabolism, immune responses, and bacterial metabolites contributing to liver disease.